日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Differences in White Matter Microstructure in Children With Type 1 Diabetes Persist During Longitudinal Follow-up: Relation to Dysglycemia

1型糖尿病患儿白质微结构差异在长期随访中持续存在:与血糖异常的关系

Mauras, Nelly; Ma, Qianheng; Weinzimer, Stuart A; White, Neil H; Tsalikian, Eva; Buckingham, Bruce; Fox, Larry A; Tamborlane, William; Arbelaez, Ana Maria; Tansey, Michael; Aye, Tandy; Cato, Allison; Hershey, Tamara; Englert, Kim; Marzelli, Matthew; Jo, Booil; Reiss, Allan

A Randomized Phase 3 Study Evaluating the Efficacy and Safety of Alogliptin in Pediatric Participants with Type 2 Diabetes Mellitus

一项评估阿格列汀治疗2型糖尿病患儿疗效和安全性的随机3期研究

Peng, Xuejun Victor; Klingensmith, Georgeanna; Hsia, Daniel S; Xie, Yunlong; Czerniak, Richard; Tamborlane, William V; Shah, Amy S

Longitudinal Effects of Glucose-Lowering Medications on β-Cell Responses and Insulin Sensitivity in Type 2 Diabetes: The GRADE Randomized Clinical Trial

降血糖药物对2型糖尿病患者β细胞反应和胰岛素敏感性的长期影响:GRADE随机临床试验

Rasouli, Neda; Younes, Naji; Ghosh, Alokananda; Albu, Jeanine; Cohen, Robert M; DeFronzo, Ralph A; Diaz, Elsa; Sayyed Kassem, Laure; Luchsinger, José A; McGill, Janet B; Sivitz, William I; Tamborlane, William V; Utzschneider, Kristina M; Kahn, Steven E

Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial

在2型糖尿病青年患者中,SGLT2抑制剂恩格列净与安慰剂以及DPP-4抑制剂利格列汀与安慰剂的疗效和安全性比较(DINAMO):一项多中心、随机、双盲、平行组、3期临床试验

Laffel, Lori M; Danne, Thomas; Klingensmith, Georgeanna J; Tamborlane, William V; Willi, Steven; Zeitler, Philip; Neubacher, Dietmar; Marquard, Jan

Comparative Effects of Glucose-Lowering Medications on Kidney Outcomes in Type 2 Diabetes: The GRADE Randomized Clinical Trial

降血糖药物对2型糖尿病肾脏结局的比较效果:GRADE随机临床试验

Wexler, Deborah J; de Boer, Ian H; Ghosh, Alokananda; Younes, Naji; Bebu, Ionut; Inzucchi, Silvio E; McGill, Janet B; Mudaliar, Sunder; Schade, David; Steffes, Michael W; Tamborlane, William V; Tan, Meng H; Ismail-Beigi, Faramarz

Unmet Needs in the Treatment of Childhood Type 2 Diabetes: A Narrative Review

儿童2型糖尿病治疗中未满足的需求:一项叙述性综述

Tamborlane, William; Shehadeh, Naim

Long-term Continuous Glucose Monitor Use in Very Young Children With Type 1 Diabetes: One-Year Results From the SENCE Study

在患有 1 型糖尿病的幼儿中长期使用连续血糖监测仪:SENCE 研究的一年结果

Van Name, Michelle A; Kanapka, Lauren G; DiMeglio, Linda A; Miller, Kellee M; Albanese-O'Neill, Anastasia; Commissariat, Persis; Corathers, Sarah D; Harrington, Kara R; Hilliard, Marisa E; Anderson, Barbara J; Kelley, Jennifer C; Laffel, Lori M; MacLeish, Sarah A; Nathan, Brandon M; Tamborlane, William V; Wadwa, R Paul; Willi, Steven M; Williams, Kristen M; Wintergerst, Kupper A; Woerner, Stephanie; Wong, Jenise C; DeSalvo, Daniel J

Impact of school-supervised ultra-long-acting basal insulin injections on ketosis in youth with T1D and elevated haemoglobin A1c: A pilot study

学校监督下超长效基础胰岛素注射对患有1型糖尿病和糖化血红蛋白A1c升高的青少年酮症的影响:一项初步研究

Nally, Laura M; Sherr, Jennifer L; Tichy, Eileen; Weyman, Kate; Urban, Andrea; Shabanova, Veronika; McCollum, Sarah; Steffen, Amy; Tamborlane, William V; Van Name, Michelle

Retinopathy During the First 5 Years of Type 1 Diabetes and Subsequent Risk of Advanced Retinopathy

型糖尿病前 5 年的视网膜病变及其后续发展为晚期视网膜病变的风险

Malone, John I; Gao, Xiaoyu; Lorenzi, Gayle M; Raskin, Philip; White, Neil H; Hainsworth, Dean P; Das, Arup; Tamborlane, William; Wallia, Amisha; Aiello, Lloyd P; Bebu, Ionut

Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study

达格列净治疗2型糖尿病儿童和青少年患者的疗效和安全性:一项前瞻性、多中心、随机、平行组3期研究

Tamborlane, William V; Laffel, Lori M; Shehadeh, Naim; Isganaitis, Elvira; Van Name, Michelle; Ratnayake, Jayantha; Karlsson, Cecilia; Norjavaara, Ensio